Novocure (NASDAQ: NVCR) announced today that it will present the final secondary endpoint results from the Phase 3 PANOVA-3 trial of its Tumor Treating Fields (TTFields) therapy for unresectable ...

Caltech scientists have found a fast and efficient way to add up large numbers of Feynman diagrams, the simple drawings ...